The Rise (and Limits) of AAV in Gene Therapy by Cristina Stoyanov
The gene therapy vector that's everywhere, but still has so far to go
Read on SubstackAccess is the Next Frontier in Cell Therapy by Cristina Stoyanov
A personal reflection on innovation, access, and the undeniable investment opportunity in delivering cell therapies at scale
Read on SubstackCell Therapies vs. Neurodegeneration by Cristina Stoyanov
A personal story and where I see breakthroughs making the leap from labs to lives.
Read on SubstackThe Scalability Signal: When Pharma Pounces by Cristina Stoyanov
Why platform technologies may be the scale engine biotech's been waiting for
Read on SubstackAre Cell Therapies at an Inflection Point? by Cristina Stoyanov
Breakthroughs in Cell Therapy Are Accelerating — Here’s Where Investors Should Look Beyond the Hype
Read on Substack